Optimal dosing of 1st line antituberculosis and antiretroviral drugs in children- a pharmacokinetic study
Description:
This study will evaluate the 2010 WHO dosing recommendations for first line antituberculosis drugs in HIV-infected and uninfected children in South Africa and Malawi.
Funding source:
US National Institute of Health
Total ammount of funding:
+/- € 1.9 million
Funding period:
2011 - 2016
Role of EfGHI:
Prof Annelies Van Rie is a co-investigator
Partner:
University of Cape Town (Helen McIlleron, PI)